Need professional-grade analysis? Visit stockanalysis.com
$2.40B
N/A
N/A
N/A
Price Chart
Risk-Adjusted Performance
Guardian Pharmacy Services, Inc. (GRDN) Price Performance
Guardian Pharmacy Services, Inc. (GRDN) trades on United States in USD. The company is classified in the Consumer Cyclical sector under the Pharmaceutical Retailers industry. The stock currently trades at $37.57, up 5.47% from the previous close.
Over the past year, GRDN has traded between a low of $19.67 and a high of $37.57. The stock has gained 85.7% over this period. It is currently 91.0% above its 52-week low.
Guardian Pharmacy Services, Inc. has a market capitalization of $2.40B.
About Guardian Pharmacy Services, Inc.
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.
Company Info
- Sector
- Consumer Cyclical
- Industry
- Pharmaceutical Retailers
- Exchange
- United States
- Currency
- USD
- Country
- United States
Financial Metrics
- Revenue (TTM)
- $1.45B
- EBITDA
- $102.62M
- Profit Margin
- 3.40%
- EPS (TTM)
- 0.78
- Book Value
- 3.25
Technical Indicators
- 52 Week High
- $37.67
- 52 Week Low
- $19.17
- 50 Day MA
- $32.08
- 200 Day MA
- $26.93
- Beta
- N/A
Valuation
- Trailing P/E
- 47.77
- Forward P/E
- 27.45
- Price/Sales
- 1.65
- Price/Book
- 11.47
- Enterprise Value
- $2.35B